The release of granzyme B a definite indicator of anti-tumour T-cell function, and has been targeted for PET imaging during immunotherapy 98, 99 with the aim to increase specificity in the detection of effective immune responses, rather than increased presence of T-cells. The gene discussed is GZMB; the disease is neoplasm.